Intracerebral Microinjection of Interleukin-4 / Interleukin-13 Reduces β-Amyloid Accumulation in the Ipsilateral Side and Improves Cognitive Deficits in Young APP 23 Mice

[1]  E. Posse de Chaves,et al.  Aβ Internalization by Neurons and Glia , 2011, International journal of Alzheimer's disease.

[2]  H. Gendelman,et al.  CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Kipnis,et al.  Regulation of learning and memory by meningeal immunity: a key role for IL-4 , 2010, The Journal of experimental medicine.

[4]  T. Ma,et al.  Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations , 2009, The Journal of Neuroscience.

[5]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[6]  M. Staufenbiel,et al.  Oral administration of synthetic retinoid Am80 (Tamibarotene) decreases brain beta-amyloid peptides in APP23 mice. , 2009, Biological & pharmaceutical bulletin.

[7]  C. Newton,et al.  CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection , 2009, Journal of Neuroimmune Pharmacology.

[8]  S. Hickman,et al.  Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice , 2008, The Journal of Neuroscience.

[9]  M. Lynch,et al.  A Pivotal Role for Interleukin-4 in Atorvastatin-associated Neuroprotection in Rat Brain* , 2008, Journal of Biological Chemistry.

[10]  Peter Tontonoz,et al.  Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors , 2007, Proceedings of the National Academy of Sciences.

[11]  C. Geula,et al.  Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.

[12]  C. Colton,et al.  Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD , 2006, Journal of Neuroinflammation.

[13]  J. Koenigsknecht-Talboo,et al.  Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines , 2005, The Journal of Neuroscience.

[14]  M. Higuchi,et al.  Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation , 2005, Nature Medicine.

[15]  M. Lynch,et al.  Role of Interleukin-4 in Regulation of Age-related Inflammatory Changes in the Hippocampus* , 2005, Journal of Biological Chemistry.

[16]  David Sweeney,et al.  Similar promotion of Aβ1-42 fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms , 2004, Journal of Neuroinflammation.

[17]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[18]  L. Danober,et al.  Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice , 2003, Neuroscience.

[19]  H. Kagechika,et al.  Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. , 2003, International immunology.

[20]  T. Shirokawa,et al.  Specific uptake of Aβ1-40 in rat brain occurs in astrocyte, but not in microglia , 2003, Neuroscience Letters.

[21]  Kazuki Sato,et al.  Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[23]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[24]  M. Mullan,et al.  Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's β-amyloid1–42 , 2002, Journal of Neuroimmunology.

[25]  Patrick L. McGeer,et al.  Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.

[26]  S. O’Mara,et al.  Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus , 2001, Behavioural Brain Research.

[27]  G. Beilman,et al.  Morphine directs T cells toward T(H2) differentiation. , 2001, Surgery.

[28]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[29]  J. Steinke,et al.  Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists , 2001, Respiratory research.

[30]  A. M. Szczepanik,et al.  IL-4, IL-10 and IL-13 modulate Aβ(1–42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line , 2001, Journal of Neuroimmunology.

[31]  I. Pastan,et al.  Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[33]  S. Paul,et al.  Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[35]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[36]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Takiguchi,et al.  Coinduction of Nitric-oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.

[38]  T. Marunouchi,et al.  Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression , 1994, Journal of Neuroimmunology.

[39]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[40]  T. Molitor,et al.  Neuroprotective role of IL-4 against activated microglia. , 1993, Journal of immunology.

[41]  中谷 矩章.  HMG-CoA Reductase Inhibitor , 1988 .

[42]  R. Morris.  Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[43]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[44]  C. A. Wiley,et al.  A Dynamic Relationship between Intracellular and Extracellular Pools of Aβ , 2007 .

[45]  R. Flavell,et al.  T-cells in alzheimer’s disease , 2007, NeuroMolecular Medicine.

[46]  J. Duffield.  The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.